Lymphoma, Low-Grade Completed Phase 2 Trials for Rituximab (DB00073)

Also known as: Low-Grade Lymphoma

IndicationStatusPhase
DBCOND0029914 (Lymphoma, Low-Grade)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00311129Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHLTreatment